CD8A and neoplasm: We demonstrated that, irrespective of the applied neoadjuvant regimen, chemotherapy led to decreased numbers of intratumoral Tregs and MDSC populations, which were accompanied by reduced aSMA+ myCAFs, and by increased proportions of CD8+ cytotoxic T lymphocytes in the tumor.